A major clinical trial of the Galleri blood test involving 142,000 NHS patients failed to reduce late-stage cancer diagnoses, its primary objective, according to results presented at an oncology conference in Chicago. While the company behind the test highlighted a 14% reduction in stage four cancers alone, independent experts said the overall findings do not justify widespread implementation.
Topicle Beta
1 comment
A major clinical trial of the Galleri blood test involving 142,000 NHS patients failed to reduce late-stage cancer diagnoses, its primary objective, according to results presented at an oncology conference in Chicago. While the company behind the test highlighted a 14% reduction in stage four cancers alone, independent experts said the overall findings do not justify widespread implementation.